Pxs-5505 | 2409963-83-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: Pxs-5505
• 英文别名: (Z)-3-fluoro-4-quinolin-8-ylsulfonylbut-2-en-1-amine
• CAS: 2409963-83-1
• 化学式: C₁₃H₁₃FN₂O₂S
• 分子量: 280.32
• InChiKey: DHXXLGDTPFPYRH-WDZFZDKYSA-N

物化性质

• 沸点：
  529.1±50.0 °C(Predicted)
• 密度：
  1.330±0.06 g/cm3(Predicted)
• 溶解度：
  DMSO：125 mg/mL（445.92 mM；需要超声波）

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  81.4
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• HALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF
  申请人：Pharmaxis Ltd.

  公开号：US20210353571A1

  公开（公告）日：2021-11-18

  The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as in pets and livestock. In addition, the present invention relates to pharmaceutical compositions containing these compounds, as well as various uses thereof.
• [EN] HALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF<br/>[FR] INHIBITEURS DE LYSYL OXYDASES DÉRIVÉS D'HALOGÉNOALLYLAMINE SULFONE ET UTILISATIONS ASSOCIÉES
  申请人：PHARMAXIS LTD

  公开号：WO2020024017A1

  公开（公告）日：2020-02-06

  The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as in pets and livestock. In addition, the present invention relates to pharmaceutical compositions containing these compounds, as well as various uses thereof.